aluates Reports

$ 0.0

Automative

Global HIV Prevention Drug Market Research Report 2024

Published Date: July 2024

Report Code: QYRE-Auto-8W17797

BUY CHAPTERS

Global HIV Prevention Drug Market Research Report 2024

Code: QYRE-Auto-8W17797

Report

July 2024

Pages:73

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Vendors

Gilead Sciences

ViiV Healthcare

HIV Prevention Drug Market

The global HIV Prevention Drug market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.

North American market for HIV Prevention Drug is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for HIV Prevention Drug is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global manufacturers of HIV Prevention Drug include Gilead Sciences, ViiV Healthcare, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for HIV Prevention Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding HIV Prevention Drug.

The HIV Prevention Drug market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global HIV Prevention Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the HIV Prevention Drug manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of HIV Prevention Drug Market Report

Report Metric	Details
Report Name	HIV Prevention Drug Market
Segment by Type	Lenacapavir Cabotegravir
Segment by Application	Hospital Clinic Others
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Gilead Sciences, ViiV Healthcare
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of HIV Prevention Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of HIV Prevention Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the HIV Prevention Drug Market report?

Ans: The main players in the HIV Prevention Drug Market are Gilead Sciences, ViiV Healthcare

What are the Application segmentation covered in the HIV Prevention Drug Market report?

Ans: The Applications covered in the HIV Prevention Drug Market report are Hospital, Clinic, Others

What are the Type segmentation covered in the HIV Prevention Drug Market report?

Ans: The Types covered in the HIV Prevention Drug Market report are Lenacapavir, Cabotegravir

Recommended Reports

HIV & AIDS Drugs

Infectious Disease Drugs

Drug Testing & Trials

1 HIV Prevention Drug Market Overview

1.1 Product Definition

1.2 HIV Prevention Drug by Type

1.2.1 Global HIV Prevention Drug Market Value Comparison by Type (2024-2030)

1.2.2 Lenacapavir

1.2.3 Cabotegravir

1.3 HIV Prevention Drug by Application

1.3.1 Global HIV Prevention Drug Market Value by Application (2024-2030)

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Others

1.4 Global HIV Prevention Drug Market Size Estimates and Forecasts

1.4.1 Global HIV Prevention Drug Revenue 2019-2030

1.4.2 Global HIV Prevention Drug Sales 2019-2030

1.4.3 Global HIV Prevention Drug Market Average Price (2019-2030)

1.5 Assumptions and Limitations

2 HIV Prevention Drug Market Competition by Manufacturers

2.1 Global HIV Prevention Drug Sales Market Share by Manufacturers (2019-2024)

2.2 Global HIV Prevention Drug Revenue Market Share by Manufacturers (2019-2024)

2.3 Global HIV Prevention Drug Average Price by Manufacturers (2019-2024)

2.4 Global Key Players of HIV Prevention Drug, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of HIV Prevention Drug, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of HIV Prevention Drug, Product Type & Application

2.7 Global Key Manufacturers of HIV Prevention Drug, Date of Enter into This Industry

2.8 Global HIV Prevention Drug Market Competitive Situation and Trends

2.8.1 Global HIV Prevention Drug Market Concentration Rate

2.8.2 The Global 5 and 10 Largest HIV Prevention Drug Players Market Share by Revenue

2.8.3 Global HIV Prevention Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global HIV Prevention Drug Market Scenario by Region

3.1 Global HIV Prevention Drug Market Size by Region: 2019 Versus 2023 Versus 2030

3.2 Global HIV Prevention Drug Sales by Region: 2019-2030

3.2.1 Global HIV Prevention Drug Sales by Region: 2019-2024

3.2.2 Global HIV Prevention Drug Sales by Region: 2025-2030

3.3 Global HIV Prevention Drug Revenue by Region: 2019-2030

3.3.1 Global HIV Prevention Drug Revenue by Region: 2019-2024

3.3.2 Global HIV Prevention Drug Revenue by Region: 2025-2030

3.4 North America HIV Prevention Drug Market Facts & Figures by Country

3.4.1 North America HIV Prevention Drug Market Size by Country: 2019 VS 2023 VS 2030

3.4.2 North America HIV Prevention Drug Sales by Country (2019-2030)

3.4.3 North America HIV Prevention Drug Revenue by Country (2019-2030)

3.4.4 United States

3.4.5 Canada

3.5 Europe HIV Prevention Drug Market Facts & Figures by Country

3.5.1 Europe HIV Prevention Drug Market Size by Country: 2019 VS 2023 VS 2030

3.5.2 Europe HIV Prevention Drug Sales by Country (2019-2030)

3.5.3 Europe HIV Prevention Drug Revenue by Country (2019-2030)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific HIV Prevention Drug Market Facts & Figures by Region

3.6.1 Asia Pacific HIV Prevention Drug Market Size by Region: 2019 VS 2023 VS 2030

3.6.2 Asia Pacific HIV Prevention Drug Sales by Region (2019-2030)

3.6.3 Asia Pacific HIV Prevention Drug Revenue by Region (2019-2030)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America HIV Prevention Drug Market Facts & Figures by Country

3.7.1 Latin America HIV Prevention Drug Market Size by Country: 2019 VS 2023 VS 2030

3.7.2 Latin America HIV Prevention Drug Sales by Country (2019-2030)

3.7.3 Latin America HIV Prevention Drug Revenue by Country

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.7.7 Colombia

3.8 Middle East and Africa HIV Prevention Drug Market Facts & Figures by Country

3.8.1 Middle East and Africa HIV Prevention Drug Market Size by Country: 2019 VS 2023 VS 2030

3.8.2 Middle East and Africa HIV Prevention Drug Sales by Country (2019-2030)

3.8.3 Middle East and Africa HIV Prevention Drug Revenue by Country

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global HIV Prevention Drug Sales by Type (2019-2030)

4.1.1 Global HIV Prevention Drug Sales by Type (2019-2024)

4.1.2 Global HIV Prevention Drug Sales by Type (2025-2030)

4.1.3 Global HIV Prevention Drug Sales Market Share by Type (2019-2030)

4.2 Global HIV Prevention Drug Revenue by Type (2019-2030)

4.2.1 Global HIV Prevention Drug Revenue by Type (2019-2024)

4.2.2 Global HIV Prevention Drug Revenue by Type (2025-2030)

4.2.3 Global HIV Prevention Drug Revenue Market Share by Type (2019-2030)

4.3 Global HIV Prevention Drug Price by Type (2019-2030)

5 Segment by Application

5.1 Global HIV Prevention Drug Sales by Application (2019-2030)

5.1.1 Global HIV Prevention Drug Sales by Application (2019-2024)

5.1.2 Global HIV Prevention Drug Sales by Application (2025-2030)

5.1.3 Global HIV Prevention Drug Sales Market Share by Application (2019-2030)

5.2 Global HIV Prevention Drug Revenue by Application (2019-2030)

5.2.1 Global HIV Prevention Drug Revenue by Application (2019-2024)

5.2.2 Global HIV Prevention Drug Revenue by Application (2025-2030)

5.2.3 Global HIV Prevention Drug Revenue Market Share by Application (2019-2030)

5.3 Global HIV Prevention Drug Price by Application (2019-2030)

6 Key Companies Profiled

6.1 Gilead Sciences

6.1.1 Gilead Sciences Company Information

6.1.2 Gilead Sciences Description and Business Overview

6.1.3 Gilead Sciences HIV Prevention Drug Sales, Revenue and Gross Margin (2019-2024)

6.1.4 Gilead Sciences HIV Prevention Drug Product Portfolio

6.1.5 Gilead Sciences Recent Developments/Updates

6.2 ViiV Healthcare

6.2.1 ViiV Healthcare Company Information

6.2.2 ViiV Healthcare Description and Business Overview

6.2.3 ViiV Healthcare HIV Prevention Drug Sales, Revenue and Gross Margin (2019-2024)

6.2.4 ViiV Healthcare HIV Prevention Drug Product Portfolio

6.2.5 ViiV Healthcare Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 HIV Prevention Drug Industry Chain Analysis

7.2 HIV Prevention Drug Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 HIV Prevention Drug Production Mode & Process

7.4 HIV Prevention Drug Sales and Marketing

7.4.1 HIV Prevention Drug Sales Channels

7.4.2 HIV Prevention Drug Distributors

7.5 HIV Prevention Drug Customers

8 HIV Prevention Drug Market Dynamics

8.1 HIV Prevention Drug Industry Trends

8.2 HIV Prevention Drug Market Drivers

8.3 HIV Prevention Drug Market Challenges

8.4 HIV Prevention Drug Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Vendors

Gilead Sciences

ViiV Healthcare

List of Tables

Table 1. Global HIV Prevention Drug Market Value Comparison by Type (2024-2030) & (US$ Million)

Table 2. Global HIV Prevention Drug Market Value by Application (2024-2030) & (US$ Million)

Table 3. Global HIV Prevention Drug Market Competitive Situation by Manufacturers in 2023

Table 4. Global HIV Prevention Drug Sales (K Units) of Key Manufacturers (2019-2024)

Table 5. Global HIV Prevention Drug Sales Market Share by Manufacturers (2019-2024)

Table 6. Global HIV Prevention Drug Revenue (US$ Million) by Manufacturers (2019-2024)

Table 7. Global HIV Prevention Drug Revenue Share by Manufacturers (2019-2024)

Table 8. Global Market HIV Prevention Drug Average Price (US$/Unit) of Key Manufacturers (2019-2024)

Table 9. Global Key Players of HIV Prevention Drug, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of HIV Prevention Drug, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of HIV Prevention Drug, Product Type & Application

Table 12. Global Key Manufacturers of HIV Prevention Drug, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global HIV Prevention Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in HIV Prevention Drug as of 2023)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global HIV Prevention Drug Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 17. Global HIV Prevention Drug Sales by Region (2019-2024) & (K Units)

Table 18. Global HIV Prevention Drug Sales Market Share by Region (2019-2024)

Table 19. Global HIV Prevention Drug Sales by Region (2025-2030) & (K Units)

Table 20. Global HIV Prevention Drug Sales Market Share by Region (2025-2030)

Table 21. Global HIV Prevention Drug Revenue by Region (2019-2024) & (US$ Million)

Table 22. Global HIV Prevention Drug Revenue Market Share by Region (2019-2024)

Table 23. Global HIV Prevention Drug Revenue by Region (2025-2030) & (US$ Million)

Table 24. Global HIV Prevention Drug Revenue Market Share by Region (2025-2030)

Table 25. North America HIV Prevention Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 26. North America HIV Prevention Drug Sales by Country (2019-2024) & (K Units)

Table 27. North America HIV Prevention Drug Sales by Country (2025-2030) & (K Units)

Table 28. North America HIV Prevention Drug Revenue by Country (2019-2024) & (US$ Million)

Table 29. North America HIV Prevention Drug Revenue by Country (2025-2030) & (US$ Million)

Table 30. Europe HIV Prevention Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 31. Europe HIV Prevention Drug Sales by Country (2019-2024) & (K Units)

Table 32. Europe HIV Prevention Drug Sales by Country (2025-2030) & (K Units)

Table 33. Europe HIV Prevention Drug Revenue by Country (2019-2024) & (US$ Million)

Table 34. Europe HIV Prevention Drug Revenue by Country (2025-2030) & (US$ Million)

Table 35. Asia Pacific HIV Prevention Drug Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 36. Asia Pacific HIV Prevention Drug Sales by Region (2019-2024) & (K Units)

Table 37. Asia Pacific HIV Prevention Drug Sales by Region (2025-2030) & (K Units)

Table 38. Asia Pacific HIV Prevention Drug Revenue by Region (2019-2024) & (US$ Million)

Table 39. Asia Pacific HIV Prevention Drug Revenue by Region (2025-2030) & (US$ Million)

Table 40. Latin America HIV Prevention Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Latin America HIV Prevention Drug Sales by Country (2019-2024) & (K Units)

Table 42. Latin America HIV Prevention Drug Sales by Country (2025-2030) & (K Units)

Table 43. Latin America HIV Prevention Drug Revenue by Country (2019-2024) & (US$ Million)

Table 44. Latin America HIV Prevention Drug Revenue Market Share by Country (2019-2024)

Table 45. Middle East and Africa HIV Prevention Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 46. Middle East and Africa HIV Prevention Drug Sales by Country (2019-2024) & (K Units)

Table 47. Middle East and Africa HIV Prevention Drug Sales by Country (2025-2030) & (K Units)

Table 48. Middle East and Africa HIV Prevention Drug Revenue by Country (2019-2024) & (US$ Million)

Table 49. Middle East and Africa HIV Prevention Drug Revenue by Country (2025-2030) & (US$ Million)

Table 50. Global HIV Prevention Drug Sales (K Units) by Type (2019-2024)

Table 51. Global HIV Prevention Drug Sales (K Units) by Type (2025-2030)

Table 52. Global HIV Prevention Drug Sales Market Share by Type (2019-2024)

Table 53. Global HIV Prevention Drug Sales Market Share by Type (2025-2030)

Table 54. Global HIV Prevention Drug Revenue (US$ Million) by Type (2019-2024)

Table 55. Global HIV Prevention Drug Revenue (US$ Million) by Type (2025-2030)

Table 56. Global HIV Prevention Drug Revenue Market Share by Type (2019-2024)

Table 57. Global HIV Prevention Drug Revenue Market Share by Type (2025-2030)

Table 58. Global HIV Prevention Drug Price (US$/Unit) by Type (2019-2024)

Table 59. Global HIV Prevention Drug Price (US$/Unit) by Type (2025-2030)

Table 60. Global HIV Prevention Drug Sales (K Units) by Application (2019-2024)

Table 61. Global HIV Prevention Drug Sales (K Units) by Application (2025-2030)

Table 62. Global HIV Prevention Drug Sales Market Share by Application (2019-2024)

Table 63. Global HIV Prevention Drug Sales Market Share by Application (2025-2030)

Table 64. Global HIV Prevention Drug Revenue (US$ Million) by Application (2019-2024)

Table 65. Global HIV Prevention Drug Revenue (US$ Million) by Application (2025-2030)

Table 66. Global HIV Prevention Drug Revenue Market Share by Application (2019-2024)

Table 67. Global HIV Prevention Drug Revenue Market Share by Application (2025-2030)

Table 68. Global HIV Prevention Drug Price (US$/Unit) by Application (2019-2024)

Table 69. Global HIV Prevention Drug Price (US$/Unit) by Application (2025-2030)

Table 70. Gilead Sciences Company Information

Table 71. Gilead Sciences Description and Business Overview

Table 72. Gilead Sciences HIV Prevention Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 73. Gilead Sciences HIV Prevention Drug Product

Table 74. Gilead Sciences Recent Developments/Updates

Table 75. ViiV Healthcare Company Information

Table 76. ViiV Healthcare Description and Business Overview

Table 77. ViiV Healthcare HIV Prevention Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 78. ViiV Healthcare HIV Prevention Drug Product

Table 79. ViiV Healthcare Recent Developments/Updates

Table 80. Key Raw Materials Lists

Table 81. Raw Materials Key Suppliers Lists

Table 82. HIV Prevention Drug Distributors List

Table 83. HIV Prevention Drug Customers List

Table 84. HIV Prevention Drug Market Trends

Table 85. HIV Prevention Drug Market Drivers

Table 86. HIV Prevention Drug Market Challenges

Table 87. HIV Prevention Drug Market Restraints

Table 88. Research Programs/Design for This Report

Table 89. Key Data Information from Secondary Sources

Table 90. Key Data Information from Primary Sources

Table 91. Authors List of This Report

List of Figures

Figure 1. Product Picture of HIV Prevention Drug

Figure 2. Global HIV Prevention Drug Market Value Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global HIV Prevention Drug Market Share by Type: 2023 & 2030

Figure 4. Lenacapavir Product Picture

Figure 5. Cabotegravir Product Picture

Figure 6. Global HIV Prevention Drug Market Value by Application (2024-2030) & (US$ Million)

Figure 7. Global HIV Prevention Drug Market Share by Application: 2023 & 2030

Figure 8. Hospital

Figure 9. Clinic

Figure 10. Others

Figure 11. Global HIV Prevention Drug Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 12. Global HIV Prevention Drug Market Size (2019-2030) & (US$ Million)

Figure 13. Global HIV Prevention Drug Sales (2019-2030) & (K Units)

Figure 14. Global HIV Prevention Drug Average Price (US$/Unit) & (2019-2030)

Figure 15. HIV Prevention Drug Report Years Considered

Figure 16. HIV Prevention Drug Sales Share by Manufacturers in 2023

Figure 17. Global HIV Prevention Drug Revenue Share by Manufacturers in 2023

Figure 18. Global 5 and 10 Largest HIV Prevention Drug Players: Market Share by Revenue in HIV Prevention Drug in 2023

Figure 19. HIV Prevention Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 20. Global HIV Prevention Drug Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Figure 21. North America HIV Prevention Drug Sales Market Share by Country (2019-2030)

Figure 22. North America HIV Prevention Drug Revenue Market Share by Country (2019-2030)

Figure 23. United States HIV Prevention Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 24. Canada HIV Prevention Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 25. Europe HIV Prevention Drug Sales Market Share by Country (2019-2030)

Figure 26. Europe HIV Prevention Drug Revenue Market Share by Country (2019-2030)

Figure 27. Germany HIV Prevention Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 28. France HIV Prevention Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 29. U.K. HIV Prevention Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 30. Italy HIV Prevention Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 31. Russia HIV Prevention Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 32. Asia Pacific HIV Prevention Drug Sales Market Share by Region (2019-2030)

Figure 33. Asia Pacific HIV Prevention Drug Revenue Market Share by Region (2019-2030)

Figure 34. China HIV Prevention Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 35. Japan HIV Prevention Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 36. South Korea HIV Prevention Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 37. India HIV Prevention Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 38. Australia HIV Prevention Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 39. China Taiwan HIV Prevention Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 40. Southeast Asia HIV Prevention Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 41. Latin America HIV Prevention Drug Sales Market Share by Country (2019-2030)

Figure 42. Mexico HIV Prevention Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 43. Brazil HIV Prevention Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 44. Argentina HIV Prevention Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 45. Colombia HIV Prevention Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 46. Middle East and Africa HIV Prevention Drug Sales Market Share by Country (2019-2030)

Figure 47. Middle East and Africa HIV Prevention Drug Revenue Market Share by Country (2019-2030)

Figure 48. Turkey HIV Prevention Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 49. Saudi Arabia HIV Prevention Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 50. UAE HIV Prevention Drug Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 51. Global Sales Market Share of HIV Prevention Drug by Type (2019-2030)

Figure 52. Global Revenue Market Share of HIV Prevention Drug by Type (2019-2030)

Figure 53. Global HIV Prevention Drug Price (US$/Unit) by Type (2019-2030)

Figure 54. Global Sales Market Share of HIV Prevention Drug by Application (2019-2030)

Figure 55. Global Revenue Market Share of HIV Prevention Drug by Application (2019-2030)

Figure 56. Global HIV Prevention Drug Price (US$/Unit) by Application (2019-2030)

Figure 57. HIV Prevention Drug Value Chain

Figure 58. HIV Prevention Drug Production Process

Figure 59. Channels of Distribution (Direct Vs Distribution)

Figure 60. Bottom-up and Top-down Approaches for This Report

Figure 61. Data Triangulation

Figure 62. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global HIV Vaccine Market Research Report 2025

Global Long acting Anti HIV Drug Market Research Report 2024

Global Anti AIDs Drug Market Insights Forecast to 2030

Global HIV Clinical Trials Market Research Report 2025

Global HIV and AIDS Clinical Trials Market Research Report 2025

Global HIV and AIDS Vaccine Market Research Report 2024

Global HIV Antiretroviral Drug Market Research Report 2025

Global Safer Sex Products Market Research Report 2024

HIV Medicines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global HIV 1 Screening Tests Market Research Report 2025

Global HIV Therapy Drug Market Research Report 2025

Anti HIV Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Human Immunodeficiency Virus Type 1 Market Research Report 2024

Global Combination Preventers Market Research Report 2025

Global Sex Products Market Research Report 2024

Human Immunodeficiency Virus HIV Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Anti Retroviral Drugs Market Research Report 2024

Global Patient Hygiene Aids Market Research Report 2024

Global BCC Drug Market Research Report 2024

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions